Saturday, November 23, 2024
Home 2023

Yearly Archives: 2023

Biotech News

Booya. We’re up 143% With Ardelyx (ARDX) in Three Months –...

Editor / Curator -
Biotech News

We Warned About VERU (VERU) $2.50, Down 89%.

Editor / Curator -
Biotech News

Silo Pharma (SILO) $2.25, Now Our Favorite Psychedelic.

Editor / Curator -
Incubator

Institutional Analyst: Our #1 Internet Company, Society Pass (Nasdaq: SOPA), Holds...

Editor / Curator -
Internet News

New Report: Society Pass (SOPA), Our #1 Internet Company Trading Under...

Editor / Curator -
Internet News

Dennis Nguyen, Founder/Chairman/CEO of Nasdaq-listed Society Pass Inc. (Nasdaq: SOPA) to...

Editor / Curator -
Incubator

Adding Principal Solar (PSWW) to Watch List.

Editor / Curator -
Psychedelic News

The Kahner Global Cannabis & Psychedelics Investment Summit.

Editor / Curator -
Marius Masalar
AI Artificial Intelligence

ChatGPT: Write a Song About Wall Street Using Style of Michael...

Editor / Curator -
Internet News

ChatGPT, the Biggest Thing Since the Internet.

Editor / Curator -
1...15161718Page 16 of 18

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.